SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:lnu-73088"
 

Search: id:"swepub:oai:DiVA.org:lnu-73088" > Inhibition of compl...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Inhibition of complement activation on a model biomaterial surface by streptococcal M protein-derived peptides

Engberg, Anna E., 1982- (author)
Högskolan i Kalmar,Naturvetenskapliga institutionen
Sandholm, Kerstin (author)
Högskolan i Kalmar,Naturvetenskapliga institutionen
Bexborn, Fredrik (author)
Högskolan i Kalmar,Naturvetenskapliga institutionen
show more...
Persson, Jenny J (author)
Lund University,Lunds universitet,Avdelningen för medicinsk mikrobiologi,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Medical Microbiology,Department of Laboratory Medicine,Faculty of Medicine
Nilsson, Bo (author)
Uppsala universitet,Enheten för klinisk immunologi
Lindahl, Gunnar (author)
Lund University,Lunds universitet,Avdelningen för medicinsk mikrobiologi,Institutionen för laboratoriemedicin,Medicinska fakulteten,Division of Medical Microbiology,Department of Laboratory Medicine,Faculty of Medicine
Nilsson Ekdahl, Kristina (author)
Uppsala universitet,Högskolan i Kalmar,Naturvetenskapliga institutionen,Uppsala University,Enheten för klinisk immunologi
show less...
 (creator_code:org_t)
Elsevier, 2009
2009
English.
In: Biomaterials. - : Elsevier. - 0142-9612 .- 1878-5905. ; 30:13, s. 2653-2659
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • The aim of this study was to evaluate a new approach to inhibit complement activation triggered by biomaterial surfaces in contact with blood. In order to inhibit complement activation initiated by the classical pathway (CP), we used streptococcal M protein-derived peptides that specifically bind human C4BP, an inhibitor of the CP. The peptides were used to coat polystyrene microtiter wells which served as a model biomaterial. The ability of coated peptides to bind C4BP and to attenuate complement activation via the CP (monitored as generation of fluid-phase C3a and binding of fragments of C3 and C4 to the surface) was investigated using diluted normal human serum, where complement activation by the AP is minimal, as well as serum from a patient lacking alternative pathway activation. Complement activation (all parameters) was significantly decreased in serum incubated in well surfaces coated with peptides. Total inhibition of complement activation was obtained at peptide coating concentrations as low as 1-5 mu g/mL. Successful use of Streptococcus-derived peptides shows that it is feasible to control complement activation at a model biomaterial surface by capturing autologous complement regulatory molecules from plasma. (C) 2009 Elsevier Ltd. All rights reserved.

Subject headings

NATURVETENSKAP  -- Biologi -- Immunologi (hsv//swe)
NATURAL SCIENCES  -- Biological Sciences -- Immunology (hsv//eng)
TEKNIK OCH TEKNOLOGIER  -- Industriell bioteknik -- Bioteknisk apparatteknik (hsv//swe)
ENGINEERING AND TECHNOLOGY  -- Industrial Biotechnology -- Bioengineering Equipment (hsv//eng)

Keyword

Blood compatibility
Complement
C4b-binding protein (C4BP)
In vitro test
Regulator of complement activation (RCA)
Streptococcal M proteins
Immunologi
Immunology
test
In vitro
C4b-binding protein (C4BP)
Blood compatibility
Complement
Regulator of complement activation (RCA)
Streptococcal M proteins
MEDICINE

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view